Table 2 Neuropsychological assessment and other clinical indicators of included participants

Global cognition

 MMSE

15 (9.5, 19)

24 (22, 26)

27 (26, 28)

< 0.001^ab

 MoCA

7 (4, 12)

18 (13.75, 21)

23 (21, 26)

< 0.001^ab

 ADL

36.5 (29, 49.75)

20 (20, 23)

20 (20, 20)

< 0.001^a

Memory

 RAVLT-I

8.5 (2, 16.25)

20.5 (14.75, 24.25)

32.5 (26.75, 41.5)

< 0.001^ab

 RAVLT-D

0 (0, 0)

0 (0, 0)

6 (4, 8)

< 0.001^ab

Executive function

 DST-Backward

3 (1.5, 3)

3 (3, 4)

4 (3, 4)

< 0.001^ab

 SCWT

24 (7, 41)

46 (38, 49)

50 (46.25, 50)

< 0.001^ab

Attention

 DST-Forward

7 (6, 8)

8 (6.75, 9)

8.5 (8, 9)

< 0.001^a

 SDMT

0 (0, 7.75)

20 (13.5, 29)

28 (20, 39.25)

< 0.001^ab

Language

 BNT

10 (7, 16.25)

19 (15, 23)

26 (23, 27.25)

< 0.001^ab

 VFT

15 (8.75, 21)

26 (23, 34)

40 (34, 49)

< 0.001^ab

Visuospatial ability

 CDT

5 (1, 17)

22 (15, 28)

26 (24, 30)

< 0.001^ab

 RCFT

0 (0, 0)

2 (0, 8.5)

11 (5, 17)

< 0.001^ab

 qEEG (abnormal%)

64.6

51.5

35.9

0.041^a

 MTA-Left

3 (2, 3)

1.5 (1, 2)

0 (0, 1)

< 0.001^a

 MTA-Right

2 (2, 3)

1 (1, 1.75)

0 (0, 1)

< 0.001^a